- The report summarizes all the dormant and discontinued pipeline projects - The report reviews latest news related to pipeline therapeutics for Visceral Pain
Reasons To Buy - Gain strategically significant competitor information , analysis , and insights to formulate effective R & D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Visceral Pain - Identify potential new clients or partners in the target demographic - Develop strategic initiatives by understanding the focus areas of leading companies - Plan mergers and acquisitions effectively by identifying key players and it ' s most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Visceral Pain pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Buy a Sample Copy of This Report @ http :// www . radiantinsights . com / research / visceral-pain-pipeline-reviewh2-2016 / request-sample
Table of Contents Table of Contents 2 List of Tables 5 List of Figures 5 Introduction 6 Global Markets Direct Report Coverage 6 Visceral Pain Overview 7 Therapeutics Development 8 Pipeline Products for Visceral Pain - Overview 8 Pipeline Products for Visceral Pain - Comparative Analysis 9 Visceral Pain - Therapeutics under Development by Companies 10 Visceral Pain - Therapeutics under Investigation by Universities / Institutes 11 Visceral Pain - Pipeline Products Glance 12 Clinical Stage Products 12 Early Stage Products 13 Visceral Pain - Products under Development by Companies 14 Visceral Pain - Products under Investigation by Universities / Institutes 15 Visceral Pain - Companies Involved in Therapeutics Development 16 Addex Therapeutics Ltd 16 Astellas Pharma Inc . 17 Chromocell Corporation 18 GIcare Pharma Inc 19 Grunenthal GmbH 20 Medestea Research & Production S . p . A . 21 Neurim Pharmaceuticals Ltd 22 Pfizer Inc . 23 Visceral Pain - Therapeutics Assessment 24 Assessment by Monotherapy Products 24 Assessment by Target 25 Assessment by Mechanism of Action 27 Assessment by Route of Administration 29 Assessment by Molecule Type 30